Peel Hunt Reaffirms “Buy” Rating for CVS Group (CVSG)

Peel Hunt reiterated their buy rating on shares of CVS Group (LON:CVSG) in a research report report published on Friday, March 29th, ThisIsMoney.Co.Uk reports.

Separately, Royal Bank of Canada lowered CVS Group to a sector performer rating and dropped their price objective for the stock from GBX 1,180 ($15.42) to GBX 600 ($7.84) in a report on Wednesday, January 30th.

Shares of LON:CVSG remained flat at $GBX 590 ($7.71) during trading on Friday. The stock had a trading volume of 319,398 shares, compared to its average volume of 234,115. The firm has a market capitalization of $415.36 million and a price-to-earnings ratio of 62.77. The company has a debt-to-equity ratio of 83.39, a quick ratio of 0.89 and a current ratio of 1.13. CVS Group has a 1-year low of GBX 362.40 ($4.74) and a 1-year high of GBX 1,191 ($15.56).

In other news, insider Richard A. Connell bought 10,000 shares of the stock in a transaction on Wednesday, January 30th. The shares were bought at an average price of GBX 407 ($5.32) per share, with a total value of £40,700 ($53,181.76).

About CVS Group

CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services.

Recommended Story: Benefits of owning preferred stock

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.